These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6798537)

  • 1. Intragastric feeding in type I glycogen storage disease: factors affecting the control of lactic acidemia.
    Stanley CA; Mills JL; Baker L
    Pediatr Res; 1981 Dec; 15(12):1504-8. PubMed ID: 6798537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycogen storage disease type I. Results of treatment with frequent daytime feeding, combined with nocturnal intragastric feeding and with administration of an alpha-glucosidase inhibitor.
    Gröbe H; Ullrich K
    Eur J Pediatr; 1983 Apr; 140(2):102-4. PubMed ID: 6411473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease.
    Greene HL; Slonim AE; O'Neill JA; Burr IM
    N Engl J Med; 1976 Feb; 294(8):423-5. PubMed ID: 813144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Continuous nocturnal intragastric feeding in glycogenosis type I and III].
    de Parscau L; Guibaud P; Hermier M; François R
    Pediatrie; 1986; 41(3):197-203. PubMed ID: 3095784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal rate of enteral glucose administration in children with glycogen storage disease type I.
    Schwenk WF; Haymond MW
    N Engl J Med; 1986 Mar; 314(11):682-5. PubMed ID: 3081806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I glycogen storage disease: five years of management with nocturnal intragastric feeding.
    Greene HL; Slonim AE; Burr IM; Moran JR
    J Pediatr; 1980 Mar; 96(3 Pt 2):590-5. PubMed ID: 6767011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen storage disease: long-term follow-up of nocturnal intragastric feeding.
    Michels VV; Beaudet AL; Potts VE; Montandon CM
    Clin Genet; 1982 Feb; 21(2):136-40. PubMed ID: 6805987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal daytime feeding regimen to prevent postprandial hypoglycemia in type 1 glycogen storage disease.
    Wolfsdorf JI; Ehrlich S; Landy HS; Crigler JF
    Am J Clin Nutr; 1992 Sep; 56(3):587-92. PubMed ID: 1503073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Home treatment of type I glycogenosis by continuous nocturnal gastric feeding].
    Chouraqui JP; Leluyer B
    Presse Med; 1986 Sep; 15(30):1405-8. PubMed ID: 2947059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous glucose for treatment of patients with type 1 glycogen-storage disease: comparison of the effects of dextrose and uncooked cornstarch on biochemical variables.
    Wolfsdorf JI; Plotkin RA; Laffel LM; Crigler JF
    Am J Clin Nutr; 1990 Dec; 52(6):1043-50. PubMed ID: 2239779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose therapy for glycogenosis type 1 in infants: comparison of intermittent uncooked cornstarch and continuous overnight glucose feedings.
    Wolfsdorf JI; Keller RJ; Landy H; Crigler JF
    J Pediatr; 1990 Sep; 117(3):384-91. PubMed ID: 2202802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical growth and development of children with type 1 glycogen-storage disease: comparison of the effects of long-term use of dextrose and uncooked cornstarch.
    Wolfsdorf JI; Rudlin CR; Crigler JF
    Am J Clin Nutr; 1990 Dec; 52(6):1051-7. PubMed ID: 2239780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dietary interventions in the maintenance of normoglycaemia in glycogen storage disease type 1a: a systematic review and meta-analysis.
    Shah KK; O'Dell SD
    J Hum Nutr Diet; 2013 Aug; 26(4):329-39. PubMed ID: 23294025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid ethanol elimination in patients with type I glycogen storage disease is an adaptive change resulting from recurrent hypoglycemia.
    Greene HL; Parker PH; Hoyumpa AM; Hall SD
    J Lab Clin Med; 1986 Feb; 107(2):118-22. PubMed ID: 3456005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I glycogen storage disease: favourable outcome on a strict management regimen avoiding increased lactate production during childhood and adolescence.
    Däublin G; Schwahn B; Wendel U
    Eur J Pediatr; 2002 Oct; 161 Suppl 1():S40-5. PubMed ID: 12373569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose production rates in type 1 glycogen storage disease.
    Collins JE; Bartlett K; Leonard JV; Aynsley-Green A
    J Inherit Metab Dis; 1990; 13(2):195-206. PubMed ID: 2116551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dietary treatment of children with type I glycogen storage disease with slow release carbohydrate.
    Smit GP; Berger R; Potasnick R; Moses SW; Fernandes J
    Pediatr Res; 1984 Sep; 18(9):879-81. PubMed ID: 6384910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of a portable lactate meter in type I glycogen storage disease.
    Saunders AC; Feldman HA; Correia CE; Weinstein DA
    J Inherit Metab Dis; 2005; 28(5):695-701. PubMed ID: 16151900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early metabolic effects of sepsis in the preterm infant: lactic acidosis and increased glucose requirement.
    Fitzgerald MJ; Goto M; Myers TF; Zeller WP
    J Pediatr; 1992 Dec; 121(6):951-5. PubMed ID: 1447665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactate as a cerebral metabolic fuel for glucose-6-phosphatase deficient children.
    Fernandes J; Berger R; Smit GP
    Pediatr Res; 1984 Apr; 18(4):335-9. PubMed ID: 6585774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.